“Documents produced by the Department of Health and Human Services (“HHS”) to the
Permanent Subcommittee on Investigations (“PSI” or “the Subcommittee”) show that beginning
in early 2021, Dr. Ana Szarfman, who at the time was a senior medical officer and safety data
mining developer at the Food and Drug Administration (“FDA”), used an updated data analysis
technique that identified dozens of statistically significant safety signals for adverse events
associated with the COVID-19 vaccines. She immediately shared her findings with other FDA
officials, including officials responsible for COVID-19 vaccine safety surveillance, but they
largely ignored her and eventually told her to stop her data analyses.”

”